[REVISION HISTORY]

Romanian cancer patients seeking overseas treatment

Updated 12 times since CLSTR started tracking revisions of this situation.

What changed

2026-10-17 15:30 UTC → 2026-10-20 10:31 UTC · added ~~removed~~

In early August 2026, Romanian model Alina Pușcău announced she had been diagnosed with multiple tumors, including formations in her chest and armpits, which had spread to her bones. She stated she would begin costly, targeted therapy at UCLA in Los Angeles, with expected costs potentially approaching half a million dollars. Two days later, a separate story highlighted another Romanian, Roxana Vălean, living in the United Kingdom and diagnosed with advanced gastric cancer. Her doctors identified an experimental PIPAC therapy available in Europe, but the £30,000 cost was beyond her family’s means. The report also referenced Pușcău’s situation, underscoring the broader financial and logistical hurdles Romanian cancer patients face when seeking advanced treatments abroad. By mid-August, Pușcău reported beginning medical treatment at UCLA, describing it as a form of local chemotherapy intended to shrink tumors or stop metastasis. She reported significant side effects, including extreme fatigue, nausea, and a weight loss of 10 kilograms. By August 20, Pușcău revealed she is participating in the ‘Destiny-Breast09’ clinical trial at UCLA, which she identified as her only viable treatment option. In early September, Pușcău continued the Destiny-Breast09 protocol, noting the treatment is more intensive than options available in Romania. She reported severe side effects, including intense pressure in her head and body, which required hospitalization for pain management. During her treatment, Pușcău launched a charitable jewelry collaboration with Loraida to raise funds for women in need of medical care. She noted that for ten days following each chemotherapy session, the physical toll is so significant that she is unable to function normally. By mid-September, she was undergoing a regimen of chemotherapy and immunotherapy every three weeks. ~~During her treatment, Pușcău emphasized~~ She expressed the ~~importance~~ emotional difficulty of ~~faith and received support from various Romanian public figures~~ the process and ~~family members. By late August, she~~ noted ~~that her heart health was a critical factor in enduring~~ the ~~intensive regimen. While other Romanians, such as George Melinte, faced similar financial hurdles seeking immunotherapy for rare sarcomas, Pușcău’s situation took a positive turn.~~ support of her mother and fans.

Versions

Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.